TMO- Thermo Fisher Scientific Inc.
Healthcare · Diagnostics & Research
Price & Performance
Performance
Analysis & Verdict
Analyst Ratings
BuyWall Street consensus from 27 analysts
12-Month Price Target
$645.15
Based on analyst estimates; price targets are opinions, not guarantees.
Fair Value Estimates
Current price: $609.82
Graham Number
√(22.5 × EPS × Book Value)
$244.18
Benjamin Graham's intrinsic value formula. Assumes a fair stock trades at no more than 22.5× the product of EPS and book value per share.
Bazin Ceiling Price
Avg. Annual DPS (5Y) ÷ 6%
$23.07
Décio Bazin's dividend-based ceiling. The max price you should pay so that dividends alone deliver at least 6% annual yield on your cost basis.
These are simplified estimates. Not financial advice.
Buy & Hold Checklist
Quality criteria for long-term holding
9/10
90% score
Pays dividends
14Y hist.14+ years of dividend history
Dividend consistency (5Y+)
14 yrsUninterrupted dividend payments for at least 5 years
ROE above 10%
13.5%Return on equity - measures how efficiently capital is used
Positive profit margin
15.0%Net profit margin must be positive - company earns more than it spends
Revenue growth (annual)
+10.5%Annual revenue must be growing compared to the prior year
Earnings growth (annual)
+9.4%Annual earnings must be growing compared to the prior year
Debt/Equity below 2×
80.58×Low financial leverage reduces risk of distress
Current ratio above 1
1.55×Short-term assets must cover short-term liabilities
Daily liquidity above $5M
$1.2B/dayHigh trading volume ensures easy entry and exit
Dividend yield above 0%
0.31%Stock must distribute income to shareholders
Financials
Revenue & Results
Key Statistics
Earnings
Next Earnings
Oct 21, 2026
38
days
EPS (TTM)
$18.60
P/E (TTM)
32.8
Fwd P/E
22.2
SEC Filings & Reported Financials
Earnings History
SEC EDGAR · official filings
SEC Filings
Official EDGAR documents
Insider Transactions
SEC Form 4 · officers, directors & 10% owners
Dividends & Income
Dividends
Current DY
0.31%
5Y Avg Annual
$1.3640
Last Payment
$0.4700
Ex-Date
06/15/2026
Annual dividends paid per share
| Ex-Date | Payment | Amount | Est. DY |
|---|---|---|---|
Latest06/15/2026 | 07/15/2026 | $0.4700 | 0.31% |
03/13/2026 | 04/12/2026 | $0.4700 | 0.31% |
12/15/2025 | 01/14/2026 | $0.4300 | 0.28% |
09/15/2025 | 10/15/2025 | $0.4300 | 0.28% |
06/13/2025 | 07/13/2025 | $0.4300 | 0.28% |
03/14/2025 | 04/13/2025 | $0.4300 | 0.28% |
12/13/2024 | 01/12/2025 | $0.3900 | 0.26% |
09/13/2024 | 10/13/2024 | $0.3900 | 0.26% |
Magic Number
Shares needed to self-fund your next purchase
$609.82
Price
$0.4700
Last div. (quarterly)
1,298
shares
Own 1,298 TMO shares ($791,546.36) and each quarterly dividend pays for 1 new share - the snowball runs on its own.
Investment target
$791,546.36
New shares / year
+4 shares
Dividend Calculator
0.31% yieldEstimate TMO dividend income at the current rate.
Per year
$30.83
Per month
$2.57
≈ 16.4 shares at $1.88/share a year. Estimate only - dividends can be cut or raised.
Tools & Simulators
TMO vs Peers, Indexes & Commodities
?Click a card below to plot it on the chart
Loading history…
Parameters
Final value
$426,404.61
Total invested
$130,000.00
Total interest
$296,404.61
Balance over time
Period breakdown
| Period | Balance | Invested | Interest |
|---|---|---|---|
| Start | $10,000.00 | $10,000.00 | $0.00 |
| Year 1 | $17,270.27 | $16,000.00 | $1,270.27 |
| Year 2 | $25,267.56 | $22,000.00 | $3,267.56 |
| Year 3 | $34,064.59 | $28,000.00 | $6,064.59 |
| Year 4 | $43,741.32 | $34,000.00 | $9,741.32 |
| Year 5 | $54,385.72 | $40,000.00 | $14,385.72 |
| Year 6 | $66,094.55 | $46,000.00 | $20,094.55 |
| Year 7 | $78,974.28 | $52,000.00 | $26,974.28 |
| Year 8 | $93,141.97 | $58,000.00 | $35,141.97 |
| Year 9 | $108,726.44 | $64,000.00 | $44,726.44 |
| Year 10 | $125,869.35 | $70,000.00 | $55,869.35 |
| Year 11 | $144,726.56 | $76,000.00 | $68,726.56 |
| Year 12 | $165,469.48 | $82,000.00 | $83,469.48 |
| Year 13 | $188,286.70 | $88,000.00 | $100,286.70 |
| Year 14 | $213,385.63 | $94,000.00 | $119,385.63 |
| Year 15 | $240,994.47 | $100,000.00 | $140,994.47 |
| Year 16 | $271,364.18 | $106,000.00 | $165,364.18 |
| Year 17 | $304,770.87 | $112,000.00 | $192,770.87 |
| Year 18 | $341,518.22 | $118,000.00 | $223,518.22 |
| Year 19 | $381,940.31 | $124,000.00 | $257,940.31 |
| Year 20 | $426,404.61 | $130,000.00 | $296,404.61 |
What is compound interest?
Compound interest means that the interest you earn in one period is added to your principal, so in the next period you earn interest on a larger base. This creates exponential growth: the longer your time horizon, the more dramatic the effect.
Which rate should I use?
The S&P 500 has historically returned ~10%/year before inflation over long periods - use this for an all-equity US index fund scenario. A balanced growth portfolio (stocks + bonds) is closer to 7%. High-yield savings accounts (HYSA) are currently paying around 4-5% with FDIC insurance and zero market risk. Bonds historically return ~4% annualized.
Formula used
FV = PV × (1+r)^n + PMT × ((1+r)^n − 1) / rwhere r is the monthly rate, n is the number of months, PV is the initial investment, and PMT is the monthly contribution. Annual rates are converted to monthly viar = (1 + annual%)^(1/12) − 1.
For educational purposes only. Not financial advice. Past returns do not guarantee future results.
Discussion
Sign in to join the discussionSign inLoading…
Discover
Related Assets
Healthcare
Related Articles
About Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines; and diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The Specialty Diagnostics segment offers clinical diagnostics products, such as liquid ready-to-use and lyophilized immunodiagnostic reagent kits, calibrators, controls, protein detection assays, and instruments; immunodiagnostic offerings comprising developing, manufacturing, and marketing of complete blood-test systems for the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; microbiology offerings, such as dehydrated and prepared culture media, collection and transport systems, instrumentation and consumables to detect pathogens in blood, diagnostic and rapid direct specimen tests, quality-control products, and associated products; transplant diagnostics products, including human leukocyte antigen typing and testing for the organ transplant market; and healthcare market channel offerings. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
Sector
Healthcare
Industry
Diagnostics & Research
Location
Waltham, United States
Employees
125,000
Stock Market ROI Pro
All features, zero ads- web & app
Unlock every feature, ad-free, across our website and iOS app.
Thermo Fisher Scientific Inc. (TMO) stock trades at $609.82, up 1.10% on the day. With a market capitalization of $225.48 billion, TMO is a mega-cap healthcare stock. It trades at a price-to-earnings (P/E) ratio of 32.8, a forward P/E of 22.2 and earnings per share (EPS) of $18.60. Over the most recent period the company reported 11% year-over-year revenue growth and a net profit margin of 15.0%. Below you'll find TMO's full fundamentals, fair-value estimates, dividend history, earnings and our buy, hold or avoid verdict for 2026.
TMO - Frequently Asked Questions
Is Thermo Fisher Scientific Inc. (TMO) a good stock to buy in 2026?
Thermo Fisher Scientific Inc. (TMO) shows strengths such as revenue growth of 11% and a strong 15% net margin, while risks include high leverage (debt/equity of 80.6). Whether TMO is a good buy in 2026 depends on your time horizon and risk tolerance - review the full bull case, bear case and fair-value estimates above. This is informational analysis, not financial advice.
What is TMO's stock price today?
Thermo Fisher Scientific Inc. (TMO) trades at $609.82, up 1.10% on the session. Prices on this page update throughout the trading day.
Does TMO pay a dividend?
Yes. Thermo Fisher Scientific Inc. pays an annual dividend of $1.88 per share, a dividend yield of 0.31%. The most recent ex-dividend date was September 15, 2026. Its payout ratio is about 10% of earnings.
Is TMO overvalued?
With a P/E ratio of 32.8×, TMO is valued above the broad-market average for the healthcare sector. Its PEG ratio is 1.80. See the Fair Value Estimates section above for Graham Number and dividend-based price targets.
What is TMO's market cap?
Thermo Fisher Scientific Inc. (TMO) has a market capitalization of $225.48 billion, classifying it as a mega-cap stock in the Healthcare sector.
Disclaimer: This page - including any buy/hold/avoid view, fair value or price estimate - is generated from market data for informational and educational purposes only and does not constitute financial, investment or trading advice. Data may be delayed or inaccurate. Always do your own research and consult a licensed financial advisor before making any investment decision.